Urgent Updates | January 18, 2024

Thirty-Eight States Experienced A ‘High‘ or Worse Level Of Influenza-Like Illness Activity During The Week Ending Dec. 30

Seasonal influenza activity is elevated and continues to increase in most parts of the country.

Outpatient respiratory illness has been above baseline nationally since November and is above baseline in all 10 HHS Regions. The number of weekly flu hospital admissions continues to increase.  CDC estimates that there have been at least 10 million illnesses, 110,000 hospitalizations, and 6,500 deaths from flu so far this season. Full Access: CDC

CDC Says JN.1 Variant Accounts for About 62% Of COVID Cases in US

The Centers for Disease Control and Prevention (CDC) reports that COVID subvariant JN.1 accounts for about 62% of cases in the U.S. as of January 2024. The agency said JN.1, which is an offspring of BA.2.86, is now the most widely circulated variant in the U.S. and globally. Full Access:  CDC

FDA Says Applesauce Pouches Recalled for Lead Also Contained Chromium

The Food and Drug Administration warned that applesauce pouches previously recalled for containing lead may also contain chromium, increasing the risks of illness after ingestion. Full Access: FDA

PF-07038124 Demonstrates Superior Efficacy in Mild to Moderate Atopic Dermatitis, Plaque Psoriasis

This randomized, double-blind clinical trial showed that the topical phosphodiesterase 4 inhibitor PF-07038124 was well tolerated and demonstrated superior efficacy in patients with mild to moderate atopic dermatitis (AD) and plaque psoriasis compared with the placebo, according to a recent phase 2a study. Full Access: JAMA